Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q4 2025 value amounting to $5.9 million.

  • Vanda Pharmaceuticals' Other Working Capital Changes rose 6343.14% to $5.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.1 million, marking a year-over-year increase of 7703.93%. This contributed to the annual value of $12.1 million for FY2025, which is 7703.93% up from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Other Working Capital Changes of $5.9 million as of Q4 2025, which was up 6343.14% from -$703000.0 recorded in Q3 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Other Working Capital Changes peaked at $13.4 million during Q1 2022, and registered a low of -$11.3 million during Q1 2023.
  • Its 5-year average for Other Working Capital Changes is $887150.0, with a median of $1.3 million in 2021.
  • Data for Vanda Pharmaceuticals' Other Working Capital Changes shows a peak YoY increase of 2682000.0% (in 2022) and a maximum YoY decrease of 39811.32% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Vanda Pharmaceuticals' Other Working Capital Changes stood at -$1.7 million in 2021, then tumbled by 104.57% to -$3.4 million in 2022, then tumbled by 108.59% to -$7.2 million in 2023, then soared by 150.58% to $3.6 million in 2024, then soared by 63.43% to $5.9 million in 2025.
  • Its last three reported values are $5.9 million in Q4 2025, -$703000.0 for Q3 2025, and $1.4 million during Q2 2025.